99% Savings - Buy Just @1 Rs X
Brimofinet is a prescription drug, available for use as Drops. Secondary and off-label uses of Brimofinet have also been mentioned below.
The optimal dosage of Brimofinet is largely dependent on the individual's body weight, medical history, gender and age. Individual symptoms and route of administration also determines the right dosage. Detailed information has been provided in the dosage section.
The most common side effects of Brimofinet are Eye Burning, Eye irritation, Stinging in the Eyes. Apart from the aforementioned side effects, Brimofinet can also lead to other problems, which have been listed below. Usually, these side effects of Brimofinet go away soon, and do not persist beyond the duration of the treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
In addition, Brimofinet's effect is Mild during pregnancy and Unknown for lactating mothers. In addition, Brimofinet's effects on the liver, heart and kidney are discussed below in the Brimofinet related warnings section.
Brimofinet is not recommended if you suffer from certain medical conditions as it can have adverse effects. Heart Failure, Diabetes, COPD (Chronic Obstructive Pulmonary Disease) are examples of such conditions. Some other conditions that can be affected by Brimofinet are listed in the contraindications section below.
Besides this, Brimofinet may also have severe interaction with some medicines. See below for a complete list.
In addition to these precautions, you may also note that Brimofinet is safe while driving, and is is addictive in nature.
Brimofinet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Adult |
|
Geriatric |
|
Is the use of Brimofinet safe for pregnant women?
Brimofinet has little to no side effects in pregnant women.
Is the use of Brimofinet safe during breastfeeding?
Due to lack of research work on this topic, the side effects of Brimofinet for breastfeeding women are not known.
What is the effect of Brimofinet on the Kidneys?
Brimofinet can have moderate side effects on the kidney. If you notice any harmful effects, stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Brimofinet on the Liver?
Brimofinet may cause harmful effects on liver. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Brimofinet on the Heart?
There may be an adverse effect on the heart after taking Brimofinet. If you observe any side effects on your body then stop taking this drug. Restart this medicine only if your doctor advises you to do so.
Brimofinet should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Brimofinet unless your doctor advises you to do so -
Is this Brimofinet habit forming or addictive?
No, there is no any evidence that Brimofinet is addictive.
Interaction between Food and Brimofinet
You can take Brimofinet with food.
Interaction between Alcohol and Brimofinet
It is difficult to say anything about the effect of Brimofinet and alcohol. No research has been done on this yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Istalol® (timolol maleate ophthalmic solution)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1401
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 153
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1405
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 154
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Alphagan® (brimonidine tartrate)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Simbrinza™ (brinzolamide/brimonidine tartrate)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Enidin® (brimonidine tartrate)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Alphagan® P (brimonidine tartrate)